ipilimumab,nivolumab,Oxaliplatin,Capecitabine,gimeracil,oteracil,tegafur,Pembrolizumab,Atezolizumab,5-Fluorouracil,Calciumfolinat,docetaxel,durvalumab
bms,Ono Pharmaceutical,nordic group,otsuka,Merck,Roche,Astrazeneca
['cm577', 'nivo']
 discussion of biomarker analysis of cm577 by al-batran 
MD-PhD, MSc
Passionate Oncologist
Focus on Molecular Oncology 
Focus on Gastrointestinal Oncology